iMetabolic Biopharma
Growth Stage
Bringing Hope to Communities Through Tech-Powered Biopharma.
Overview
Raised: $365,915
Total Commitments ($USD)
Platform
StartEngine
Start Date
12/18/2022
Close Date
07/06/2023
Min. Goal
$10,000
Max. Goal
$1,230,000
Min. Investment
$250
Security Type
Convertible Note
Series
Seed
SEC Filing Type
RegCF
Valuation Cap
$25,000,000
Discount
10%
Rolling Commitments ($USD)
Status
Funded
Reporting Date
07/30/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,839
# of Investors
281
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
IMetabolic Biopharma, with a valuation of $25 million, is raising funds on StartEngine. It is an early-stage drug discovery company developing new, life-saving drugs to fight against some of today's most devastating chronic diseases. IMetabolic Biopharma technology-powered iPlatform™ pipeline removes the roadblocks that typically make drug development slow, expensive, and inefficient. Currently the company is pre-market. Urban Austin Kiernan founded the company in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,230,000. The campaign proceeds will be used for Therapeutic asset research and development, software research and development, executive compensation and working capital.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-94,513 |
$-63,745 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$4,601 |
$64,248 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$4,601 |
$64,248 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$161,025 |
$155,471 |
|
Total Liabilities |
$161,025 |
$155,471 |
Financials as of: 12/18/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.